Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a General Ward
Launched by RIGSHOSPITALET, DENMARK · Jul 29, 2025
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how practical and helpful it is to use a wireless device that continuously monitors vital signs—like heart rate, breathing, oxygen levels, blood pressure, and temperature—in patients having surgery to correct adult spinal deformity. The device is worn on the chest and sends real-time information to nurses in a general hospital ward. The study aims to see if nurses find this technology easy to use and useful, and if patients are comfortable wearing the device after their surgery. It will also check how well the device works compared to the usual method of monitoring vital signs.
Adults scheduled for spinal surgery involving at least five vertebrae and expected to stay in the hospital for more than three days may be eligible to participate. Nurses working in the orthopedic ward who have experience with this monitoring system can also take part. Participants can expect to wear a small, chest-mounted sensor after surgery while their health is closely tracked without needing to be connected to machines by wires. This study hopes to improve patient care by making it easier for nurses to spot any health changes early and respond quickly. People with pacemakers, allergies to the device, or who don’t speak Danish won’t be able to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Included are adult patients (\>=18 years) scheduled for ASD surgery with estimated a \>3 day expected post-operative stay. ASD-surgery is defined as a posterior instrumented fusion of at least five spinal levels including instrumentation to the pelvis, caused by a degenerative condition of the spine.
- • Registered nurses and nurses' assistants employed at the orthopedic ward during the study period will be included if they have experience working with wCVSM during the study period. The study includes both sexes, variation of level of education and years of work experience. Included nurses and nurses' assistants should be proficient in the Danish language.
- Exclusion Criteria:
- • Exclusion criteria are patients who are unable to wear continuous monitoring due to a pacemaker or allergy.
- • Patients who are not proficient in the Danish language will be excluded.
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported